J Frontier Co

J Frontier Co AAQS

The The AAQS of J Frontier Co (2934.T) as of Oct 17, 2026 is 1. In the previous year, The AAQS was 1.00 — a change of 0.00% (lower).

AAQS

1

YoY

0.00%

Last updated:

J Frontier Co has a current AAQS of 1.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock J Frontier Co in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The J Frontier Co AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2019
1.00 JPY
Jan 1, 2020
1.00 JPY
Jan 1, 2021
1.00 JPY
Jan 1, 2022
1.00 JPY
Jan 1, 2023
1.00 JPY
Jan 1, 2024
1.00 JPY
Jan 1, 2025
1.00 JPY
Jan 1, 2026
1.00 JPY
The J Frontier Co AAQS history
YEARAAQSYoY
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
10.00%
1—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

J Frontier Co Stock analysis

What does J Frontier Co do? J Frontier Co Ltd, listed on the Tokyo Stock Exchange under ticker 2934.T, is a healthcare company headquartered in Shibuya-Ku, Tokyo. The company went public on August 27, 2021, and currently employs 255 full-time staff. J Frontier operates through three business segments focused on healthcare products and services. The Healthcare Sales segment handles the planning, development, and distribution of health foods and cosmetics, including the 328 selection series of fermented hydrogen products, alongside mail-order sales. The Medical Care Sales segment manages dispensing pharmacies, mail-order sales of ethical drugs, and the development and distribution of pharmaceuticals such as the Why Pure series and Chinese herbs. The Health Care Marketing segment provides advertising services, sales promotion support, and wholesale of in-house products for healthcare-related businesses. The company’s website is https://jfrontier.jp/. J Frontier does not disclose specific financial figures or details about its founding year, key executives, or acquisition history beyond the publicly available information. It is categorized under the Health Care sector and Industry in financial databases. The company’s operations are based in Shibuya-Ku, Tokyo, and it serves customers through both direct sales and online channels. No additional product names, historical milestones, or personnel details are provided in the available data. J Frontier Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about J Frontier Co stock

The AAQS of J Frontier Co is 1 in 2026.

On Eulerpool you can find the complete historical development of The AAQS J Frontier Co since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — J Frontier Co

All Key Metrics — J Frontier Co